Outset Medical (OM) Net Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -377.34% |
| Dec 31, 2025 | 70.18% |
| Sep 30, 2025 | 91.42% |
| Jun 30, 2025 | 24.37% |
| Mar 31, 2025 | -153.00% |
| Dec 31, 2024 | 2,084.41% |
| Sep 30, 2024 | -180.45% |
| Jun 30, 2024 | 115.64% |
| Mar 31, 2024 | -212.79% |
| Dec 31, 2023 | 35,497.80% |
| Sep 30, 2023 | -555.00% |
| Jun 30, 2023 | 100.05% |
| Mar 31, 2023 | -78.34% |
| Dec 31, 2022 | -77.75% |
| Sep 30, 2022 | 70.09% |
| Jun 30, 2022 | 42.87% |
| Mar 31, 2022 | -41.20% |
| Dec 31, 2021 | -10.04% |
| Sep 30, 2021 | -294.46% |
| Jun 30, 2021 | 152.09% |
| Mar 31, 2021 | -164.17% |
| Dec 31, 2020 | -108.23% |
| Sep 30, 2020 | 1,649.54% |
| Jun 30, 2020 | -110.60% |
| Mar 31, 2020 | 5,385.41% |